227 related articles for article (PubMed ID: 7902209)
21. The N-terminal common domain of simian virus 40 large T and small t antigens acts as a transformation suppressor of the HER-2/neu oncogene.
Lin YC; Peng JM; Wang WB
Oncogene; 2000 May; 19(22):2704-13. PubMed ID: 10851070
[TBL] [Abstract][Full Text] [Related]
22. [Effect of E1A gene on in vitro growth inhibition and radiochemosensitivity of lymph node metastasis cells of human head and neck squamous cell carcinoma].
Wang XL; Qian XL; Zhao QZ; Xu ZG; Tang PZ
Ai Zheng; 2003 Nov; 22(11):1140-6. PubMed ID: 14613640
[TBL] [Abstract][Full Text] [Related]
23. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
Sikes RA; Chung LW
Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
[TBL] [Abstract][Full Text] [Related]
24. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
Dougall WC; Qian X; Peterson NC; Miller MJ; Samanta A; Greene MI
Oncogene; 1994 Aug; 9(8):2109-23. PubMed ID: 7913542
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
26. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
27. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
Qian X; Dougall WC; Hellman ME; Greene MI
Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
[TBL] [Abstract][Full Text] [Related]
28. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
29. [Effects of E1A gene on the growth and chemosensitivity of transplantation tumor of nude mice].
Wang XL; Qian XL; Zhao QZ; Xu ZG; Tang PZ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 38(6):409-12. PubMed ID: 15040099
[TBL] [Abstract][Full Text] [Related]
30. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.
Dougall WC; Qian X; Greene MI
J Cell Biochem; 1993 Sep; 53(1):61-73. PubMed ID: 7901229
[TBL] [Abstract][Full Text] [Related]
31. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
32. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
34. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
De Santes K; Slamon D; Anderson SK; Shepard M; Fendly B; Maneval D; Press O
Cancer Res; 1992 Apr; 52(7):1916-23. PubMed ID: 1348016
[TBL] [Abstract][Full Text] [Related]
35. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence.
Matin A; Hung MC
Oncogene; 1994 May; 9(5):1333-9. PubMed ID: 7908732
[TBL] [Abstract][Full Text] [Related]
36. E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection.
Cook JL; Wilson BA; Wolf LA; Walker TA
Oncogene; 1993 Mar; 8(3):625-35. PubMed ID: 8437846
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo.
Drebin JA; Link VC; Greene MI
Oncogene; 1988 Mar; 2(3):273-7. PubMed ID: 2451200
[TBL] [Abstract][Full Text] [Related]
38. While E1A can facilitate epithelial cell transformation by several dominant oncogenes, the C-terminus seems only to regulate rac and cdc42 function, but in both epithelial and fibroblastic cells.
Fischer RS; Quinlan MP
Virology; 2000 Apr; 269(2):404-19. PubMed ID: 10753719
[TBL] [Abstract][Full Text] [Related]
39. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S
Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]